- The Wall Street Journal•3 hours ago
The Treasury Department spent nearly three years reshaping international corporate transactions and deterring inversions. Now, all that work, capped with a crucial set of final rules in October, could ...
- Zacks•5 hours ago
Pfizer Inc. (PFE) announced positive top-line results from a phase III study evaluating its marketed drug, Lyrica (pregabalin), as adjunctive therapy for the treatment of pediatric patients suffering from epilepsy with partial-onset seizures.
PFE : Summary for Pfizer, Inc. Common Stock - Yahoo Finance
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Bid||31.69 x 17300|
|Ask||31.70 x 7100|
|Day's Range||31.36 - 31.73|
|52 Week Range||28.25 - 37.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||31.77|
|Dividend & Yield||1.20 (3.73%)|
|1y Target Est||N/A|